Shawn Tomasello - 29 Mar 2022 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
Director
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
ALVR
Transactions as of
29 Mar 2022
Transactions value $
$0
Form type
4
Filing time
31 Mar 2022, 17:20:13 UTC
Previous filing
03 Jan 2022
Next filing
19 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALVR Stock Option (Right to Buy) Award $0 +45K $0.00 45K 29 Mar 2022 Common Stock 45K $7.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in twelve (12) equal quarterly installments, with the first installment vesting on June 29, 2022.